Construction of monomeric ZnPc-loaded nanoparticles with MnO2 shell for enhanced photo- and chemodynamic cancer therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Photodynamic therapy for cancer10.1038/nrc1071 ↗
2. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers10.1038/nm.2933 ↗
3. Recent advances in strategies to enhance photodynamic and photothermal therapy performance of single-component organic phototherapeutic agents
4. Tumor microenvironment-modulated nanoparticles with cascade energy transfer as internal light sources for photodynamic therapy of deep-seated tumors10.1016/j.biomaterials.2024.122743 ↗
5. Mitochondrion-targeted type I photodynamic therapy for agonist independent cGAS-STING activation
6. NIR-II light activated photosensitizer with aggregation-induced emission for precise and efficient two-photon photodynamic cancer cell ablation
7. pH-responsive AIE nanogels for synergistic chemo-photodynamic cancer therapy with imaging guidance10.1007/s11426-024-2379-x ↗
8. Engineering hierarchical metal-organic@metal-DNA heterostructures for combinational tumor treatment10.1007/s12274-023-5909-2 ↗
9. Engineering of upconverted metal–organic frameworks for near-infrared light-triggered combinational photodynamic/chemo-/immunotherapy against hypoxic tumors10.1021/jacs.9b12788 ↗
10. Zinc(II) phthalocyanines as photosensitizers for antitumor photodynamic therapy10.1016/j.biocel.2019.105575 ↗
11. The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer10.1039/C9CS00129H ↗
12. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape10.1016/j.biomaterials.2012.07.025 ↗
13. An upconversion nanoparticle-Zinc phthalocyanine based nanophotosensitizer for photodynamic therapy10.1016/j.biomaterials.2014.01.068 ↗
14. Synthesis and optimization of ZnPc-loaded biocompatible nanoparticles for efficient photodynamic therapy10.1039/C6TB00307A ↗
15. The photophysicochemical properties and photodynamic therapy activity of phenyldiazenyl phenoxy substituted phthalocyanines when incorporated into pluronic® F127 micelles10.1016/j.poly.2019.114157 ↗
16. Poly(oxanorbornene)s bearing triphenylphosphonium and PEGylated zinc(II) phthalocyanine with boosted photobiological activity and singlet oxygen generation10.1039/D2PY01297A ↗
17. Effects of aggregation on the structures and excited-state absorption for zinc phthalocyanine10.1039/D2CP04372F ↗
18. Preparation of aggregation-free ZnPc-doped nanophotosensitizers for highly efficient photodynamic therapy
19. Managing the TME to improve the efficacy of cancer therapy10.3389/fimmu.2022.954992 ↗
20. Tumor microenvironment and cancer therapy resistance10.1016/j.canlet.2015.07.044 ↗
21. Tumor microenvironment: barrier or opportunity towards effective cancer therapy10.1186/s12929-022-00866-3 ↗
22. Potentiating photodynamic therapy of ICG-loaded nanoparticles by depleting GSH with PEITC10.1039/C9NR01306G ↗
23. Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy10.1016/j.cej.2020.127212 ↗
24. Enhancement of tumor lethality of ROS in photodynamic therapy10.1002/cam4.3592 ↗
25. Conquering the hypoxia limitation for photodynamic therapy10.1002/adma.202103978 ↗
26. H2O2 self-supplying and GSH-depleting nanoplatform for chemodynamic therapy synergetic photothermal/chemotherapy10.1021/acsami.1c10341 ↗
27. A potent strategy of combinational blow toward enhanced cancer chemo-photodynamic therapy via sustainable GSH elimination
28. Innovative strategies for photodynamic therapy against hypoxic tumor
29. Strategic design of conquering hypoxia in tumor for advanced photodynamic therapy
30. Biomimetic yolk–shell nanocatalysts for activatable dual-modal-image-guided triple-augmented chemodynamic therapy of cancer10.1021/acsnano.2c08077 ↗
31. All-in-one theranostic nanomedicine with ultrabright second near-infrared emission for tumor-modulated bioimaging and chemodynamic/photodynamic therapy10.1021/acsnano.0c00082 ↗
32. Modulation of hypoxia in solid tumor microenvironment with MnO2 nanoparticles to enhance photodynamic therapy10.1002/adfm.201600676 ↗
33. Engineering MnO2 nanomulberries for enhancing PTT/PDT synergistic cancer therapy10.1002/adtp.202300281 ↗
34. MnO2-based bioresponsive nanoplatform synergizing mitochondrial metabolism modulation for amplified phototherapy and chemodynamic therapy of melanoma10.1016/j.cej.2024.158757 ↗
35. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields10.1021/cr400407a ↗
36. A PDA-DTC/Cu–MnO2 nanoplatform for MR imaging and multi-therapy for triple-negative breast cancer treatment10.1039/D1CC00987G ↗
37. Bioactive glasses-based nanozymes composite macroporous cryogel with antioxidative, antibacterial, and pro-healing properties for diabetic infected wound repair10.1002/adhm.202302073 ↗
38. One-pot synthesis of a self-reinforcing cascade bioreactor for combined photodynamic/chemodynamic/starvation therapy10.1016/j.jcis.2021.03.173 ↗
39. A novel reactive oxygen species nano-amplifier for tumor-targeted photoacoustic imaging and synergistic therapy10.1016/j.jcis.2024.11.183 ↗
40. Multi-Energy integrated photocatalysis for antitumor therapy10.1002/EXP.20240188 ↗
41. Analysis of drug combinations: current methodological landscape10.1002/prp2.149 ↗
42. Iron consumption strengthens anti-tumoral STING activation mediated by manganese-based nanoparticles10.1016/j.nantod.2024.102446 ↗
43. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy10.1038/s41422-020-00395-4 ↗
44. Manganese galvanic cells intervene in tumor metabolism to reinforce cGAS-STING activation for bidirectional synergistic hydrogen-immunotherapy
45. A single-atom Mn/MoO3-x nanoagonist for cascade cGAS/STING activation in tumor-specific catalytic metalloimmunotherapy